Matignon Technologies

investment firm

About

MT is a euro 50 M closed-end venture capital fund dedicated to investments in unlisted innovative, early-stage companies.

Details

Industries
Venture Capital
Operating Status
Active
Investor Type
Venture Capital

Matignon Technologies is a euro 50 M closed-end venture capital fund dedicated to investments in unlisted innovative, early-stage companies specialized in high technologies with strong growth potential. The Fund invests as a minority shareholder with a stake comprised between euro 0.5 M and 3.0 M euro. Subscriptions were closed in September 2000 and the Fund has a lifespan of six years.

Investments

Number of Investments
Number of Lead Investments
9
3
Matignon Technologies has made 9 investments. Their most recent investment was on Sep 21, 2010, when Arterial Remodeling Technologies raised $8.50M.
Date Company Name
Round Money Raised Industry Lead Investor
Series Unknown $8.50M Biotechnology
Jul 19, 2010 Gentis
Series Unknown $548.26K Biotechnology
May 5, 2010 Nanobiotix
Series C €7M Biotechnology
Oct 7, 2008 Orteq
Series B £8M Biotechnology Yes
Series Unknown €5.50M Biotechnology Yes

Exits

Matignon Technologies has had 2 exits. Matignon Technologies most notable exits include Nanobiotix ,   Alveolus

Date Company Name Exit Type Industry
Dec 10, 2020 Nanobiotix IPO Biotechnology Detail
Feb 19, 2009 Alveolus M&A Medical Detail